Citiation Virology antiviral research
Articles published in Journal of Virology & Antiviral Research have been cited by esteemed scholars and scientists all around the world. Journal of Virology & Antiviral Research has got h-index 10, which means every article in Journal of Virology & Antiviral Research has got 10 average citations.
Following are the list of articles that have cited the articles published in Journal of Virology & Antiviral Research.
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
Year wise published articles |
30 | 22 | 24 | 10 | 15 |
Year wise citations received |
59 | 42 | 46 | 41 | 45 |
| Journal total citations count | 353 |
| Journal Impact Factor | 1.35 |
| Journal 5 years Impact Factor | 2.85 |
| Journal CiteScore | 2.52 |
| Journal h-index | 10 |
| Journal h-index since 2017 | 8 |
Singh, K. (2020). In vitro anti-HIV activity of some Indian medicinal plant extracts. BMC Complementary and Alternative Medicine, 20. |
Talwar, G. P., & Gupta, J. C. Development of a Wide Spectrum Microbicide Basant and Three Meritorious Strains of Probiotic lactobacilli for Restoration and Maintenance of Healthy Vagina. Group, 5, 6-25. |
GP, T., & Gupta, J. C. Two Products to Prevent and Maintain Healthy Vagina. |
Talwar, G. P. C. Gupta J, Kavita Garg et al.(2018) BASANT, a Polyherbal Formulation Prevents Sexually Transmitted Infec-tions, Cures Vaginosis and Maintains Vagina Healthy. Int J Sex Health Repro Health, 1(1), 1-4. |
Mujahid, M. (2016). Prevention is better than Cure-AIDS: A Short Review. Microbiol Int J, 1(2), 108. |
Mannem, A. B. Research and Reviews: Research Journal of Biology. |
Mujahid, M., & Ghani, F. Research & Reviews: Journal of Medical and Health Sciences. AIDS, 54, 55. |
GP, T., & Gupta, J. C. Two Useful Safe Products for Maintaining Healthy Vagina and Prevention of Infection with Human Papilloma Virus leading to Carcinoma of Cervix. |
Rojas Sanchez, P., Dominguez, S., Jimenez De Ory, S., Prieto, L., Rojo, P., Mellado, P., ... & Holguin, A. (2018). Trends in drug resistance prevalence, HIV-1 variants and clinical status in HIV-1-infected pediatric population in Madrid: 1993 to 2015 analysis. The Pediatric Infectious Disease Journal, 37(3), e48-e57. |
Rojas Sanchez, P., Dominguez, S., Jimenez De Ory, S., Prieto, L., Rojo, P., Mellado, P., ... & Holguin, A. (2018). Trends in drug resistance prevalence, HIV-1 variants and clinical status in HIV-1-infected pediatric population in Madrid: 1993 to 2015 analysis. The Pediatric Infectious Disease Journal, 37(3), e48-e57. |
Alvarez, P., Fernández McPhee, C., Prieto, L., Martín, L., Obiang, J., Avedillo, P., ... & Holguín, Á. (2016). HIV-1 Variants and drug resistance in pregnant women from BATA (Equatorial Guinea): 2012-2013. PloS one, 11(10), e0165333. |
Alvarez, P., Fernández McPhee, C., Prieto, L., Martín, L., Obiang, J., Avedillo, P., ... & Holguín, Á. (2016). HIV-1 Variants and drug resistance in pregnant women from BATA (Equatorial Guinea): 2012-2013. PloS one, 11(10), e0165333. |
Sánchez, P. R., Domínguez, S., De Ory, S. J., Prieto, L., Rojo, P., Mellado, P., ... & Holguín, Á. (2018). Trends in drug resistance prevalence, HIV-1 variants and clinical status in HIV-1-infected pediatric population in Madrid: 1993 to 2015 analysis. The Pediatric Infectious Disease Journal, 37(3), e48-e57. |
Prieto-Tato, L. M., Vargas, A., Álvarez, P., Avedillo, P., Nzi, E., Abad, C., ... & Obiang, J. (2016). Diagnóstico precoz de la infección por el virus de la inmunodeficiencia humana-1 en niños: programa de prevención de la transmisión maternoinfantil en Guinea Ecuatorial. Enfermedades Infecciosas y Microbiología Clínica, 34(9), 566-570. |
Llácer Delicado, T. (2018). Variabilidad natural en los sitios de procesamiento viral y en posiciones asociadas a resistencias antirretrovirales de la proteasa, retrotranscriptasa e integrasa en las variantes del VIH-1. |
Rojas Sanchez, P. (2017). Análisis de la variabilidad genética y de resistencias a antirretrovirales en la cohorte de niños y adolescentes infectados por VHI-1 de la Comunidad de Madrid. |
Mannem, A. B. Research and Reviews: Research Journal of Biology. |
Mannem, A. B. Research and Reviews: Research Journal of Biology. |
Mujahid, M., & Ghani, F. Research & Reviews: Journal of Medical and Health Sciences. AIDS, 54, 55. |
Muller, V. D., Soares, R. O., dos Santos-Junior, N. N., Trabuco, A. C., Cintra, A. C., Figueiredo, L. T., ... & Aquino, V. H. (2014). Phospholipase A2 isolated from the venom of Crotalus durissus terrificus inactivates dengue virus and other enveloped viruses by disrupting the viral envelope. PLoS One, 9(11), e112351. |
Shimizu, J. F., Pereira, C. M., Bittar, C., Batista, M. N., Campos, G. R. F., da Silva, S., ... & Jardim, A. C. G. (2017). Multiple effects of toxins isolated from Crotalus durissus terrificus on the hepatitis C virus life cycle. PLoS One, 12(11), e0187857. |
Russo, R. R., dos Santos Júnior, N. N., Cintra, A. C. O., Figueiredo, L. T. M., Sampaio, S. V., & Aquino, V. H. (2019). Expression, purification and virucidal activity of two recombinant isoforms of phospholipase A 2 from Crotalus durissus terrificus venom. Archives of virology, 164(4), 1159-1171. |
Poloni, T. R., Dornas, F. P., dos Santos Jr, N. N., Soares, A. M., Amarilla, A. A., Alfonso, H. L., ... & Aquino, V. H. (2016). High prevalence of clinically unsuspected dengue disease among children in Ribeirao Preto City, Brazil. Journal of medical virology, 88(10), 1711-1719. |
Punger?ar, J., Bihl, F., Lambeau, G., & Kriaj, I. (2021). What do secreted phospholipases A2 have to offer in combat against different viruses up to SARS-CoV-2?. Biochimie, 189, 40-50. |
Quintana, A. (2017). Produção e atividade antiviral das isoformas da fosfolipase A2 crotoxina B recombinante (Doctoral dissertation, UNIVERSIDADE DE SÃO PAULO). |
Quintana, A. (2017). Produção e atividade antiviral das isoformas da fosfolipase A2 crotoxina B recombinante (Doctoral dissertation, UNIVERSIDADE DE SÃO PAULO). |
Russo, R. R. Produção e atividade antiviral das isoformas da fosfolipase A2 crotoxina B recombinante (Doctoral dissertation, Universidade de São Paulo). |
Mujahid, M. (2016). Prevention is better than Cure-AIDS: A Short Review. Microbiol Int J, 1(2), 108. |
Tavakoli, A., Karbalaie Niya, M. H., Keshavarz, M., Ghaffari, H., & Esghaei, M. (2017). Mechanisms Involved in Immunopathogenesis of influenza virus infection. Journal of Fasa University of Medical Sciences, 7(2), 162-171. |
Tavakoli, Ahmad, Karbalaeinia, Mohammad Hadi, Keshavarz, Mohsen, ... & Esqaei. (2017). Mechanisms involved in the immunopathogenesis of influenza virus infection. Journal of Fasa University of Medical Sciences , 7 (2), 162-171. |
Mujahid, M. (2016). Prevention is better than Cure-AIDS: A Short Review. Microbiol Int J, 1(2), 108. |
Helaly, G. F., El Ghazzawi, E. F., Shawky, S. M., & Farag, F. M. (2015). Occult hepatitis B virus infection among chronic hemodialysis patients in Alexandria, Egypt. Journal of infection and public health, 8(6), 562-569. |
El?Mowafy, M., Elgaml, A., El?Mesery, M., & Elegezy, M. (2017). Molecular analysis of Hepatitis B virus sub?genotypes and incidence of preS1/preS2 region mutations in HBV?infected Egyptian patients from Mansoura. Journal of medical virology, 89(9), 1559-1566. |
Elbedewy, A. T., Elshweikh, A. S., & Baiomy, N. (2016). Prevalence and significance of hepatitis-B core antibodies among hepatitis B surface antigen-negative Egyptian patients on hemodialysis in Al-Gharbia governorate. Tanta Medical Journal, 44(2), 33. |
Elbedewy, A. T., Elshweikh, A. S., & Baiomy, N. (2016). Prevalence and significance of hepatitis-B core antibodies among hepatitis B surface antigen-negative Egyptian patients on hemodialysis in Al-Gharbia governorate. Tanta Medical Journal, 44(2), 33. |
Athbi, H. A., & Jasim, N. A. (2015). Prevalence and Risk Factors for Hepatitis Cand B Viruses Infection among Hemodialysis Patients in Holy Karbala, Iraq. Kufa Journal for Nursing Sciences, 5(3), 4. |
Abdel?Maksoud, N. H., El?Shamy, A., Fawzy, M., Gomaa, H. H., & Eltarabilli, M. M. (2019). Hepatitis B variants among Egyptian patients undergoing hemodialysis. Microbiology and immunology, 63(2), 77-84. |
Nasir, N. A., & Abdilazeem, M. A. (2019). Prevalence of Viral Hepatitis B, C, and Human Immunodeficiency Virus among End Stage Renal Disease Patients on Hemodialysis. Iraqi Postgraduate Medical Journal, 18(2). |
Bozaci, I., & Tosun, S. (2021). The Relationship of Hepatits B Core Antibody Positivity with Demographic and Laboratory Parameters in Hemodialysis Patients. Medical Bulletin of Haseki/Haseki Tip Bulteni, 59(3). |
Samadi, E., Mirshahabi, H., Motamed, N., & Sadeghi, H. (2020). Prevalence of Occult Hepatitis B Virus Infection in Hemodialysis Patients Using Nested PCR. Reports of Biochemistry & Molecular Biology, 9(1), 82. |
Mustafa, M. O., Enan, K. A., Elkhidir, I. M., & El Hussein, A. R. M. (2019). Sci Forschen. |
Mujahid, M. (2016). Prevention is better than Cure-AIDS: A Short Review. Microbiol Int J, 1(2), 108. |
Jacob, S., Gopal, T., Kanagasabai, S., Durairaj, A., Sushi, K., & Arumugam, G. (2015). Herpes Simplex Virus 2 infection in HIV-seropositive individuals in Tamil Nadu, India. International Journal of Medical Science and Public Health, 4(3), 404-407. |
Jacob, S., Gopal, T., Kanagasabai, S., Durairaj, A., Sushi, K., & Arumugam, G. (2015). Herpes Simplex Virus 2 infection in HIV-seropositive individuals in Tamil Nadu, India. International Journal of Medical Science and Public Health, 4(3), 404-407. |
Oti, V. B., Usman, B. A., Pennap, G. R., & Eno-Ibanga, C. K. (2017). Seroprevalence of Herpes Simplex Virus Type 2 (HSV-2) among pregnant women accessing antenatal care in a tertiary healthcare Facility in Central Nigeria. Asian Journal of Research in Medical and Pharmaceutical Sciences, 1-6. |
Singh, M. K., Halthur, K. S., Kandati, J., Narukuru, P., & Basava, S. P. R. (2016). Seroepidemiological study of Herpes simplex virus 2 in human immuno deficiency virus-positive individuals attending a tertiary care hospital of South India. International Journal of Community Medicine and Public Health, 3(9), 2381. |
de Souza, A., & Madhusudana, S. N. (2014). Survival from rabies encephalitis. Journal of the neurological sciences, 339(1-2), 8-14. |
Appolinario, C. M., & Jackson, A. C. (2015). Antiviral therapy for human rabies. Antiviral therapy, 1-10. |
Jackson, A. C. (2014). Recovery from rabies: a call to arms. Journal of the neurological sciences, 339(1), 5-7. |
Marosi, A., Dufkova, L., Forró, B., Felde, O., Erdélyi, K., irmarová, J., ... & Bakonyi, T. (2019). Combination therapy of rabies-infected mice with inhibitors of pro-inflammatory host response, antiviral compounds and human rabies immunoglobulin. Vaccine, 37(33), 4724-4735. |
Anindita, P. D., Sasaki, M., Nobori, H., Sato, A., Carr, M., Ito, N., ... & Sawa, H. (2016). Generation of recombinant rabies viruses encoding NanoLuc luciferase for antiviral activity assays. Virus research, 215, 121-128. |
Anindita, P. D., Sasaki, M., Okada, K., Ito, N., Sugiyama, M., Saito-Tarashima, N., ... & Sawa, H. (2018). Ribavirin-related compounds exert in vitro inhibitory effects toward rabies virus. Antiviral research, 154, 1-9. |
Smreczak, M., Or?owska, A., Marzec, A., Tr?bas, P., Kycko, A., Reichert, M., ... & ?mudzi?ski, J. F. (2019). The effect of combined drugs therapy on the course of clinical rabies infection in a murine model. Vaccine, 37(33), 4701-4709. |
Roy, S., Mukherjee, S., Pawar, S., & Chowdhary, A. (2016). Evaluation of in vitro antiviral activity of Datura metel Linn. against rabies virus. Pharmacognosy research, 8(4), 265. |
Marosi, A., Forgách, P., Gyuranecz, M., Sulyok, K. M., & Bakonyi, T. (2019). Evaluation of in vitro inhibitory potential of type-I interferons and different antiviral compounds on rabies virus replication. Vaccine, 37(33), 4663-4672. |
Marosi, A., Forgách, P., Gyuranecz, M., Sulyok, K. M., & Bakonyi, T. (2019). Evaluation of in vitro inhibitory potential of type-I interferons and different antiviral compounds on rabies virus replication. Vaccine, 37(33), 4663-4672. |
Marosi, A., Forgách, P., Gyuranecz, M., Sulyok, K. M., & Bakonyi, T. (2019). Evaluation of in vitro inhibitory potential of type-I interferons and different antiviral compounds on rabies virus replication. Vaccine, 37(33), 4663-4672. |
Lama, Z., Gaudin, Y., Blondel, D., & Lagaudrière-Gesbert, C. (2019). Kinase inhibitors tyrphostin 9 and rottlerin block early steps of rabies virus cycle. Antiviral research, 168, 51-60. |
Lama, Z., Gaudin, Y., Blondel, D., & Lagaudrière-Gesbert, C. (2019). Kinase inhibitors tyrphostin 9 and rottlerin block early steps of rabies virus cycle. Antiviral research, 168, 51-60. |
Smith, S. P., Wu, G., Fooks, A. R., Ma, J., & Banyard, A. C. (2019). Trying to treat the untreatable: experimental approaches to clear rabies virus infection from the CNS. Journal of General Virology, 100(8), 1171-1186. |
Smith, S. P., Wu, G., Fooks, A. R., Ma, J., & Banyard, A. C. (2019). Trying to treat the untreatable: experimental approaches to clear rabies virus infection from the CNS. Journal of General Virology, 100(8), 1171-1186. |
Smith, S. P., Wu, G., Fooks, A. R., Ma, J., & Banyard, A. C. (2019). Trying to treat the untreatable: experimental approaches to clear rabies virus infection from the CNS. Journal of General Virology, 100(8), 1171-1186. |
Roy, S., Samant, L., Ganjhu, R., Mukherjee, S., & Chowdhary, A. (2018). Assessment of in vivo antiviral potential of Datura metel Linn. extracts against rabies virus. Pharmacognosy research, 10(1), 109. |
Bourhy, H., de Melo, G. D., & Tarantola, A. (2020). Nouveaux aspects de la lutte contre la rage. Bulletin de l'Académie Nationale de Médecine, 204(9), 1000-1009. |
Sengupta, S., Paul, P., Mukherjee, B., Gaonkar, R. H., Debnath, M. C., Chakraborty, R., ... & Roy, S. (2018). Peripheral nerve targeting by procaine-conjugated ribavirin-loaded dual drug nanovesicle. Nanomedicine, 13(23), 3009-3023. |
Jackson, A. C., & Edwards, M. S. (2017). Treatment of rabies. UpToDate. Waltham, MA: UpToDate Inc. |
Anindita, P. D. (2017). Development and Implementation of a Compound Screening Assay to Identify Antivirals against Rabies Virus (Doctoral dissertation, ?????). |
Mujahid, M. (2016). Prevention is better than Cure-AIDS: A Short Review. Microbiol Int J, 1(2), 108. |
Farahtaj, F., Gholami, A., Khosravy, M. S., Gharibzadeh, S., Niknam, H. M., & Ghaemi, A. (2021). Enhancement of immune responses by co-stimulation of TLR3-TLR7 agonists as a potential therapeutics against rabies in mouse model. Microbial Pathogenesis, 157, 104971. |
Farahtaj, F., Gholami, A., Khosravy, M. S., Gharibzadeh, S., Niknam, H. M., & Ghaemi, A. (2021). Enhancement of immune responses by co-stimulation of TLR3-TLR7 agonists as a potential therapeutics against rabies in mouse model. Microbial Pathogenesis, 157, 104971. |
Marte, K. (2015). The effect of type-I interferons, and the antiviral drugs ribavirin and favipiravir on rabies virus replication in mouse neuroblastoma (N2A) cells (Doctoral dissertation). |
Marte, K. (2015). The effect of type-I interferons, and the antiviral drugs ribavirin and favipiravir on rabies virus replication in mouse neuroblastoma (N2A) cells (Doctoral dissertation). |
Bourhy, H., de Melo, GD, & Tarantola, A. (2020). New aspects of rabies control. Bulletin of the National Academy of Medicine . |
Bourhy, H., de Melo, GD, & Tarantola, A. (2020). New aspects of rabies control. Bulletin of the National Academy of Medicine . |
Ismail, R. H. (2015). Vitamin D Deficiency and Immune Function in African American, HIV-Infected Men (Doctoral dissertation, Walden University). |
Mujahid, M. (2016). Prevention is better than Cure-AIDS: A Short Review. Microbiol Int J, 1(2), 108. |
Hassan, M. Z., Osman, H., Ali, M. A., & Ahsan, M. J. (2016). Therapeutic potential of coumarins as antiviral agents. European journal of medicinal chemistry, 123, 236-255. |
Zhao, C., Rakesh, K. P., Ravidar, L., Fang, W. Y., & Qin, H. L. (2019). Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review. European journal of medicinal chemistry, 162, 679-734. |
Gupta, S., Mishra, K. P., & Ganju, L. (2017). Broad-spectrum antiviral properties of andrographolide. Archives of virology, 162(3), 611-623. |
Chikhale, R. V., Gurav, S. S., Patil, R. B., Sinha, S. K., Prasad, S. K., Shakya, A., ... & Prasad, R. S. (2020). Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach. Journal of Biomolecular Structure and Dynamics, 1-12. |
Fang, W. Y., Ravindar, L., Rakesh, K. P., Manukumar, H. M., Shantharam, C. S., Alharbi, N. S., & Qin, H. L. (2019). Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: A critical review. European journal of medicinal chemistry, 173, 117-153. |
Vora, J., Patel, S., Sinha, S., Sharma, S., Srivastava, A., Chhabria, M., & Shrivastava, N. (2019). Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV. Journal of Biomolecular Structure and Dynamics, 37(1), 131-146. |
Diwaker, D., Mishra, K. P., Ganju, L., & Singh, S. B. (2014). Rhodiola inhibits dengue virus multiplication by inducing innate immune response genes RIG-I, MDA5 and ISG in human monocytes. Archives of virology, 159(8), 1975-1986. |
Sharma, N., Mishra, K. P., Chanda, S., Bhardwaj, V., Tanwar, H., Ganju, L., ... & Singh, S. B. (2019). Evaluation of anti-dengue activity of Carica papaya aqueous leaf extract and its role in platelet augmentation. Archives of virology, 164(4), 1095-1110. |
Khan, Z., Karata?, Y., Ceylan, A. F., & Rahman, H. (2021). COVID-19 and therapeutic drugs repurposing in hand: the need for collaborative efforts. Le Pharmacien Hospitalier et Clinicien, 56(1), 3-11. |
Sharma, N., Mishra, K. P., & Ganju, L. (2016). Salidroside exhibits anti-dengue virus activity by upregulating host innate immune factors. Archives of virology, 161(12), 3331-3344. |
Xu, L., Wu, Y. L., Zhao, X. Y., & Zhang, W. (2015, June). The study on biological and pharmacological activity of coumarins. In Asia-Pacific Energy Equipment Engineering Research Conference;(AP3ER 2015) (pp. 135-138). |
Xu, L., Wu, Y. L., Zhao, X. Y., & Zhang, W. (2015, June). The study on biological and pharmacological activity of coumarins. In Asia-Pacific Energy Equipment Engineering Research Conference;(AP3ER 2015) (pp. 135-138). |
Tjandrawinata, R. R., Susanto, L. W., & Nofiarny, D. (2017). The use of Phyllanthus niruri L. as an immunomodulator for the treatment of infectious diseases in clinical settings. Asian Pac. J. Trop. Dis, 7(3), 132-140. |
Ornano, L., Feroci, M., Guarcini, L., Venditti, A., & Bianco, A. (2018). Anti-HIV agents from nature: natural compounds from Hypericum hircinum and carbocyclic nucleosides from iridoids. In Studies in Natural Products Chemistry (Vol. 56, pp. 173-228). Elsevier. |
Jansi, R. S., Khusro, A., Agastian, P., Alfarhan, A., Al-Dhabi, N. A., Arasu, M. V., ... & Al-Tamimi, A. (2021). Emerging paradigms of viral diseases and paramount role of natural resources as antiviral agents. Science of The Total Environment, 759, 143539. |
Hussain, W., Amir, A., & Rasool, N. (2020). Computer-aided study of selective flavonoids against chikungunya virus replication using molecular docking and DFT-based approach. Structural Chemistry, 1-12. |
Anagha, K., Manasi, D., Priya, L., & Meera, M. (2014). Scope of Glycyrrhiza glabra (Yashtimadhu) as an antiviral agent: a review. Int. J. Curr. Microbiol. App. Sci, 3(12), 657-665. |
Anagha, K., Manasi, D., Priya, L., & Meera, M. (2014). Scope of Glycyrrhiza glabra (Yashtimadhu) as an antiviral agent: a review. Int. J. Curr. Microbiol. App. Sci, 3(12), 657-665. |
Zhibin, L., & Jiping, Y. (2015). Health related quality of life: is it another comprehensive evaluation indicator of Chinese medicine on acquired immune deficiency syndrome treatment?. Journal of Traditional Chinese Medicine, 35(5), 600-605. |
Prajapati, A. S., Raval, S. K., Sinha, S., Varia, T. N., & Mashiyava, P. H. (2015). Effect of Phyllanthus amarus on serum biochemical changes in azaserine induced pancreatic cancer in Wistar rats. Veterinary world, 8(8), 937. |
Gyawali, R., Paudel, P. N., Basyal, D., Setzer, W. N., Lamichhane, S., Paudel, M. K., ... & Khanal, P. (2020). A review on ayurvedic medicinal herbs as remedial perspective for COVID-19. Journal of Karnali Academy of Health Sciences, 3. |
Radhakrishnan, N., Lam, K. W., & Norhaizan, M. E. (2017). Molecular docking analysis of Carica papaya Linn constituents as antiviral agent. International Food Research Journal, 24(4). |
Mujahid, M., & Ghani, F. More Newly Characterized Viruses in Coming Days. virus, 61, 66. |
Rasool, N., Bakht, A., & Hussain, W. (2021). Analysis of inhibitor binding combined with reactivity studies to discover the potentially inhibiting phytochemicals targeting Chikungunya viral replication. Current drug discovery technologies, 18(3), 437-450. |
